Status:
UNKNOWN
The Efficacy Of Complete Mesocolic Excision With Central Vessel Ligation Technique On Lymph Nodes And Safety Margins Compared With Conventional Surgery For Colon Cancer Treatment
Lead Sponsor:
Assiut University
Conditions:
Cancer Colon
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cancer Colon is one of the major public health problems worldwide. Complete eradication of the tumor with no recurrence or residual masses is a challenge which faces all the surgeons and medical staff...
Eligibility Criteria
Inclusion
- • Adult male and female Age of or above 18 years.
- Tumor localization at the caecum, ascending colon, transverse colon, descending colon, sigmoid colon or rectosigmoid on preoperative endoscopy and radiographic imaging \[barium enema or computed tomography (CT)\]
- No history of familial adenomatous polyposis, ulcerative colitis or Crohn's disease
- Written informed consent
Exclusion
- • Contraindications to major surgery and American Society of Anaesthesiologists (ASA) Physical Status scoring 4 which means extreme systemic disorders which have already become an eminent threat to life regardless of the type of treatment.
- Infectious disease requiring treatment.
- Pregnant women
- Use of systemic steroids.
- Severe pulmonary emphysema or pulmonary fibrosis
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04079946
Start Date
October 1 2019
End Date
June 1 2021
Last Update
September 6 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.